Louisiana 2022 2022 Regular Session

Louisiana Senate Bill SB329 Comm Sub / Analysis

                    The original instrument and the following digest, which constitutes no part of the
legislative instrument, were prepared by Brandi Cannon.
DIGEST
SB 329 Original	2022 Regular Session	Fred Mills
Proposed law provides that a licensed pharmacist may, independently or with one or more similarly
licensed pharmacists, engage in practice with one or more practitioners in accordance with a written
agreement, subject to administrative rules promulgated by the La. Board of Pharmacy.
Proposed law provides that a licensed pharmacist may render approved patient care services
including but not limited to smoking cessation therapy and travel health services, in accordance with
a statewide patient care service protocol developed by the Public Health and Pharmacy Protocol
Advisory Committee.
Proposed law provides that the protocols for patient care services by pharmacists may authorize a
pharmacist to prescribe and dispense any of the following: prescription medications, excluding
controlled substances, prescription devices, and durable medical equipment. Proposed law further
provides that a pharmacist may order and administer laboratory tests when authorized by a written
agreement pursuant to proposed law or patient care service protocol.
Proposed law provides for the Public Health and Pharmacy Protocol Advisory Committee consisting
of seven members for the purpose of recommending statewide protocols for patient care services.
Proposed law further provides for the term of committee members and filling of vacancies, officers,
and reimbursement of travel expenses.
Present law defines "pharmacy collaborative drug therapy management".
Proposed law repeals present law.
Effective August 1, 2022.
(Adds R.S. 37:1220 and 1220.1; repeals R.S. 37:1164(39))